跳至主要内容
临床试验/ACTRN12619001506189
ACTRN12619001506189终止4 期

Detection of Testosterone Microdosing in Healthy Men with an emphasis on profiling effect of the WADA’s Athletes Biological Passport (ABP)

Sydney local Health District0 个研究点目标入组 6 人开始时间: 2019年10月31日最近更新:

试验速览

阶段
4 期
状态
终止
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
Male

入选标准

  • Healthy men aged over 18 years of age
  • Provide written, informed consent and willing to comply with all study requirements

排除标准

  • Contraindications to testosterone administration (prostate or breast cancer, untreated sleep apnea or polycythemia)
  • Allergy to peanuts
  • Bleeding disorder or taking anti-coagulant drugs
  • Major, serious or chronic medical disorders including chronic viral infections (HIV, hepatitis) requiring regular prescribed medication;
  • Regular use of medications that interferes with metabolism of testosterone
  • History of androgen or other drug abuse within last year
  • Major psychiatric disease or psychological condition that limits understanding and compliance with study requirements in the opinion of the investigator
  • Men in competitive sporting teams subject to WADA or other occupational drug testing that would disclose testosterone administration

研究者

相似试验